Implications of T Cell-Mediated Tumor Killing Genes for Molecular Heterogeneity and Clinical Stratification in Lung Adenocarcinoma

Tong Qiao,Beining Yin,Jun Liang,Li Wei
DOI: https://doi.org/10.1016/j.gendis.2023.101162
IF: 7.376
2024-01-01
Genes & Diseases
Abstract:Due to the profound heterogeneity exhibited amongst pa-tients with lung adenocarcinoma(LUAD),considerable vari-ances in clinical efficacy emerge.1 For the aims of precision medicine,a clinical instrument to delineate distinct disease phenotypes and anticipate susceptibility to intervention is imperative.Cellular cytotoxicity mediated through T lym-phocytes constitutes a pivotal mechanism of anti-tumoral immunity and the foundation for cancer immunotherapy.2 Numerous genes regulating the sensitivity of tumor cells to killing mediated by T lymphocytes(GSTKKs)are conducive to satisfying the aforesaid medical necessity.
What problem does this paper attempt to address?